Lilly will launch its Mounjaro obesity drug in Denmark next week, the U.S. drugmaker said on Thursday, bringing competition ...

Eli Lilly (NYSE:LLY) is reportedly preparing to launch its drug Mounjaro in Denmark, the home country of its leading rival in the weight-loss drug market, Novo Nordisk (NVO). Lilly (LLY) plans to ...

A staggering 64% of adults in England are classed as either overweight or obese according to the most recent NHS figures. And ...

A weight-loss drug more effective than Ozempic and Wegovy has recently been approved. Here’s how it works and how it compares ...

The U.S. Food and Drug Administration (FDA) is rethinking its decision to remove popular weight-loss and diabetes drugs from ...

In a reversal, the FDA is reconsidering its decision to end the shortage status of tirzepatide, after a recent lawsuit and intense public pressure, The Washington Post reported Oct. 21.

Here are insights into Tori Spelling’s weight loss journey and how the actress toned herself down. From medications to diet ...

The reconsideration follows an Oct. 11 lawsuit that prompted U.S. District Judge Mark Pittman to temporarily halt legal proceedings to give the FDA time to reassess its ruling.

Both Wegovy and Mounjaro are given as weekly injections via pre-filled pens that can be self-administered into the upper arm, ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound were no longer in shortage after nearly two years. Pharmacies that sold unbranded ...

For once, the U.K.’s health technology assessment body, the National Institute of Health and Care Excellence (NICE), has no reservations about the cost effectiveness of a new drug and is recommending ...

,A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia. The drug, tirzepatide, is sold under the brand name Mounjaro and affects feelings of hunger and ...